Executive Board 

Sandra LaCava - Executive Director
After 23 years in the business world, Sandra came to the nonprofit sector with a wealth of organizational and management experience. She has spent time working for a hospice in Northeast Ohio and more recently with a nonprofit serving young children and their families in Phoenix, AZ. Sandra earned her Masters in Education from the University of Arizona and has put that expertise to use in elementary schools and community colleges, and in the non-profit sector training teachers, employees, and volunteers. She is an advocate for a healthy lifestyle at the personal and global level. This interest in health has influenced her life through the study of physiology, nutrition, alternative medicine, yoga and meditation. It is with this passion and the memory of her mother’s experience with cancer that she dedicates her service to the cause of the Dorothy Foundation.

 

Scientific Advisory Board 

Joshua LaBaer, Director, Virginia G. Piper Center for Personal Diagnostics, Biodesign Institute, Arizona State University - Medical Advisory Board

Joshua LaBaer, M.D., Ph.D., formerly the Director of the Harvard Institute of Proteomics (HIP), is the Piper Chair in Personalized Medicine, Director of the Virginia G. Piper Center for Personalized Diagnostics and the Chair of the Directorate of the Biodesign Institute. His efforts involve leveraging the Center’s formidable resources for the discovery and validation of biomarkers—unique molecular fingerprints of disease—which can provide early warning for those at risk of major illnesses, including cancer and diabetes. He completed medical
and graduate school at the University of California, San Francisco where he studied steroid regulation of DNA transcription and protein-DNA interactions. He completed his internship and residency at the Brigham and Women’s Hospital and a clinical fellowship in Oncology at the Dana-Farber Cancer Institute in Boston. Dr. LaBaer is a member of the National Cancer Institute Board of Scientific Advisors. Recently he was elected Chair of the EDRN Executive Committee and Co-Chair of the Steering Committee. Dr. LaBaer serves as an associate editor of the Journal of Proteome Research, and a member of the editorial boards of Analytical Chemistry, Current Opinion in Biotechnology, Cancer Biomarker, Molecular Biosystems, and Clinical Proteomics. He is treasurer for US Human Proteome Organization (USHUPO) and a member of the Scientific Advisory Committee for Plexera, jlabaer@asu.edu

Daniel Rubin, ND, FABNO  - Medical Advisory Board

Dr. Rubin’s practice of naturopathic oncology has been an integral part of the Phoenix metropolitan medical community for the past 14 years. After graduating from Southwest College of Naturopathic Medicine (SCNM) in 1997, Dr. Rubin returned to SCNM to complete his residency. During his residency Dr. Rubin began breaking new ground as he: 1) became the first naturopathic physician to integrate into Maricopa Medical Center; 2) developed an international presence; and 3) launched a focused naturopathic oncology practice. In 2004, Dr. Rubin became the Founding President of the Oncology Association of Naturopathic Physicians (OncANP). The OncANP represented a revolution for the field of naturopathic oncology providing, for the first time, definition, validation and standardization of the field of naturopathic oncology; an international movement was launched, as the OncANP became the first-of-its-kind in naturopathic medicine o to create an organization based on a medical-specialty structure. OncANP then created the American Board of Naturopathic Oncology, its board certification arm, which began certifying physicians to become naturopathic oncologists in 2006. Today, OncANP has become the model for other naturopathic specialty organizations with a continually expanding membership base and currently over 50 naturopathic oncologists in practice in North America. Dr. Rubin is co-Founder (along with his wife, Debi Smolinski, ND) and Medical Director of Naturopathic Specialists, LLC, in Scottsdale, AZ, where he practices full-time as a naturopathic oncologist. Dr. Rubin’s global mission is to provide the choice of naturopathic oncology for all people diagnosed with cancer across the globe. Dr. Rubin is an expert at the integration of traditional and naturopathic medicine for people with cancer. He was raised in Glencoe, IL, and his family is still back in Glencoe and the suburbs of Chicago.

Frank L. Meyskens, MD  - Medical Advisory Board

The long term interest of Dr. Meyskens laboratory has been the development of experimental and clinical therapies based on knowledge of the transformation process in the cell type. Current efforts are focused on characterizing the role of the redox-sensitice transcription factors NFKB and AP-1 on regulating cell growth and the effects of antioxidants, redox mimetic, NFKB inhibitors, and apoptosis and chemoprevention of human cancer.
Dr. Meyskens also conducts several large clinical chemoprevention trials involving oral, colon and prostate sites with polyamine synthesis inhibitor and protease inhibitor as the major drugs of interest. This is ample opportunity to do basic molecular mechanistic and correlative studies using tissues from these trials.